£76.38

Springer Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 1 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days • 37 data points

Historical
Generating forecast...
£76.38 £72.56 £74.09 £75.62 £77.14 £78.67 £80.20 01 May 2026 10 May 2026 19 May 2026 28 May 2026 06 June 2026

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £76 Days at Price

Price Analysis

Most common price: £76 (37 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 37 days

Description

Motor dysfunction and cognitive impairment are major symptoms in both Huntington’s Disease (HD) and Parkinson’s Disease (PD). A breakthrough in HD research was the identification of the gene that causes this devastating monogenetic illness. Similarly, several genes were found to cause familial forms of PD. With their identification, a plethora of genetic animal models has been generated and has revolutionized the understanding of the pathobiology and pathophysiology of these disorders. The models allow us to study the earliest manifestations of the diseases behaviorally and neuropathologically and help us understand how they progress over time. Additionally, neurotoxic animal models are still of high interest to the PD field, as they are being used to study e.g. mitochondrial dysfunction in PD. This book focuses on animal models of both diseases and how they have helped and will continue to help understand the behavioral neurobiology in these disorders. From the Back Cover Motor dysfunction and cognitive impairment are major symptoms in both Huntington’s Disease (HD) and Parkinson’s Disease (PD). A breakthrough in HD research occurred in 1993, with the identification of the gene causing this devastating monogenetic illness. Since 1996, several genes were reported to cause familial forms of PD. Following these genetic discoveries, a variety of genetic disease models were generated, providing completely novel opportunities to explore the neurobiological basis of HD and PD. Genetic models allow us to study the earliest manifestations of the diseases both behaviorally and neuropathologically, and provide tools to probe molecular pathways of neurodegeneration. Additionally, neurotoxic animal models allow us to reproduce neurochemical and cellular events of great pathophysiological importance. In the PD field, neurotoxic animal models remain the preferred option to reproduce symptomatic features of the human disease that are responsive to dopaminergic pharmacotherapies. In addition, neurotoxic PD models are often used to investigate pathways of mitochondrial dysfunction, oxidative stress, and neuroinflammation. This book provides up-to-date reviews on current animal models of both HD and PD. These animal models are essential to investigate links between the pathobiology and the behavioral abnormalities associated with these disorders.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 October 2016
Listed Since
19 October 2016

Barcode

No barcode data available

Similar Products You Might Like

The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy: 217 (Advances in Anatomy, Embryology and Cell Biology, 217)
83% match

The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy: 217 (Advances in Anatomy, Embryology and Cell Biology, 217)

Springer

£73.90 18 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
83% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£143.49 24 May 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
83% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£141.23 24 May 2026
Neurological and Psychiatric Disorders (Current Clinical Neurology)
83% match

Neurological and Psychiatric Disorders (Current Clinical Neurology)

Humana

£103.24 01 Jun 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
82% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£50.21 20 May 2026
Neuropsychiatric Disorders
82% match

Neuropsychiatric Disorders

Springer

£107.98 27 May 2026
Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive
82% match

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

Springer

£60.49 05 Jun 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
82% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Genetics and Genomics of Neurobehavioral Disorders (Contemporary Clinical Neuroscience)
81% match

Genetics and Genomics of Neurobehavioral Disorders (Contemporary Clinical Neuroscience)

Humana

£107.98 24 May 2026
Huntington's Disease: Prevalence, Pathogenesis & Treatment (Neurology-laboratory and Clinical Research Developments)
81% match

Huntington's Disease: Prevalence, Pathogenesis & Treatment (Neurology-laboratory and Clinical Research Developments)

£119.99 29 May 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
81% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 24 May 2026
Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders
81% match

Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders

Academic Press

£145.99 21 May 2026
81% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Academic Press

£157.99 20 May 2026
Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)
81% match

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Humana

£121.64 25 May 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
81% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 05 Jun 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
80% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 29 May 2026
Mitochondrial Dynamics and Neurodegeneration
80% match

Mitochondrial Dynamics and Neurodegeneration

Springer

£107.98 02 Jun 2026
Animal Models of Behavioral Analysis: 50 (Neuromethods, 50)
80% match

Animal Models of Behavioral Analysis: 50 (Neuromethods, 50)

Humana

£104.18 21 May 2026
Computational Neuroscience Models of the Basal Ganglia (Cognitive Science and Technology)
80% match

Computational Neuroscience Models of the Basal Ganglia (Cognitive Science and Technology)

Springer

£118.26 06 Jun 2026
Psych Cog Disorders Parkinson Dis
80% match

Psych Cog Disorders Parkinson Dis

Cambridge University Press

£50.45 06 Jun 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
80% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£107.98 25 May 2026
Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)
80% match

Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)

Springer

£93.13 29 May 2026
Ethical Issues in Behavioral Neuroscience: 19 (Current Topics in Behavioral Neurosciences, 19)
80% match

Ethical Issues in Behavioral Neuroscience: 19 (Current Topics in Behavioral Neurosciences, 19)

Springer

£107.98 26 May 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
80% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Academic Press

£156.19 19 May 2026